67 physicians back New Jersey senator for use of hydroxychloroquine to address COVID-19

Written by Alan Condon | March 24, 2020 | Print  |

Backing New Jersey State Sen. Joe Pennacchio on March 23, a total of 67 physicians advocated for the use of hydroxychloroquin to combat the spread of the novel coronavirus, according to Tap Into.

Mr. Pennachio called for federal and state governments to use HCQ to tackle the spread of COVID-19, the illness caused by the novel coronavirus, in response to a peer-reviewed study by French infectious disease specialist Didier Raoult, MD, PhD.

In the study, Dr. Raoult demonstrated positive results for the treatment of COVID-19 with HCQ, which has the ability to prevent the virus from entering the cell as well as reproducing.

Dr. Raoult found a substantial decrease in "viral shedding" from patients treated with HCQ, which reduces the likelihood of  the virus being transmitted to others.

HCQ also has a 22-day half-life within the body, reinforcing its efficacy for the treatment of COVID-19.

More articles on practice management:
NuVasive recalls Magec system for scoliosis, advises surgeons to perform clinical follow-ups
Zimmer Biomet asks European hospitals to remove orthopedic spacer molds
Resurgens Orthopaedics postpones elective surgeries, remains open for urgent care

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers